Phase 1 Trial of Palbociclib With Chemotherapy for Solid Tumors
Safety, tolerability, and efficacy of palbociclib in combination with cisplatin or carboplatin among patients with advanced/metastatic solid tumors.
All articles by Cancer Therapy Advisor Staff
Phase 1 Dose Escalation Study of SBRT for Head and Neck Cancer
Researchers are evaluating the maximum tolerated dose and efficacy of SBRT with cisplatin among patients with recurrent or unresectable squamous cell carcinoma of the head and neck.
Phase 2 Trial of Ablation Techniques in Metastatic Sarcoma
Researchers are attempting to determine whether cryoablation, radiofrequency ablation, or microwave ablation are feasible, safe, and effective.
Phase 2 Trial of TAK-228 for PI3K-dysregulated Sarcoma
Researchers are evaluating whether TAK-228, a novel, orally administered mTOR inhibitor, is efficacious among patients with unresectable or metastatic soft tissue sarcoma.
Trial of Radiotherapy for Lung Metastases in Soft Tissue Sarcoma
Researchers are evaluating stereotactic body radiation therapy with adaptive radiation therapy for the treatment of non-resectable lung metastases from a primary soft tissue sarcoma.
Proton Therapy Trial Among Patients With Stage I NSCLC
Researchers are evaluating whether hypoIGRT is an effective treatment strategy for patients with stage I NSCLC who are not candidates for surgery.
Phase 3 Trial of SPECT/CT Imaging for Lung Cancer
Researchers are attempting to determine whether SPECT/CT imaging is non-inferior to PET/CT imaging for lung cancer.
Phase 1/2 Study of Tadalafil + Vaccine in HNSCC
Researchers are evaluating whether tadalafil improves the response to vaccination among patients with recurrent head and neck squamous cell carcinoma.
Phase 1b/2 Study of DPX-E7 + Cyclophosphamide in HPV-positive Cancers
Researchers are evaluating whether DPX-E7 vaccination is safe and will improve outcomes among patients with HPV-positive head and neck, cervical, or anal cancer.
Phase 2 Study of ADXS 11-001 Vaccination in HPV-positive Oropharyngeal Squamous Cell Carcinoma
Researchers are evaluating whether ADXS 11-001 vaccination prior to transoral surgery will improve outcomes for patients with HPV-positive oropharyngeal cancer.
- Loading...
Loading...
Next post in Head and Neck Cancer
Loading... 
Loading...